Annual Cash & Cash Equivalents
$69.27 M
+$22.01 M+46.59%
December 31, 2023
Summary
- As of February 7, 2025, STRO annual cash & cash equivalents is $69.27 million, with the most recent change of +$22.01 million (+46.59%) on December 31, 2023.
- During the last 3 years, STRO annual cash & cash equivalents has fallen by -$136.88 million (-66.40%).
- STRO annual cash & cash equivalents is now -66.40% below its all-time high of $206.15 million, reached on December 31, 2020.
Performance
STRO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$174.58 M
+$83.79 M+92.29%
September 30, 2024
Summary
- As of February 7, 2025, STRO quarterly cash and cash equivalents is $174.58 million, with the most recent change of +$83.79 million (+92.29%) on September 30, 2024.
- Over the past year, STRO quarterly cash and cash equivalents has increased by +$105.31 million (+152.03%).
- STRO quarterly cash and cash equivalents is now -25.74% below its all-time high of $235.09 million, reached on June 30, 2023.
Performance
STRO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
STRO Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +46.6% | +152.0% |
| 3 y3 years | -66.4% | +152.0% |
| 5 y5 years | -44.7% | +152.0% |
STRO Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +127.8% | -25.7% | +504.1% |
| 5 y | 5-year | -66.4% | +1296.5% | -25.7% | +3419.7% |
| alltime | all time | -66.4% | +1296.5% | -25.7% | +3419.7% |
Sutro Biopharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $174.58 M(+92.3%) |
| Jun 2024 | - | $90.79 M(+39.2%) |
| Mar 2024 | - | $65.22 M(-5.8%) |
| Dec 2023 | $69.27 M(+46.6%) | $69.27 M(-15.4%) |
| Sep 2023 | - | $81.83 M(-65.2%) |
| Jun 2023 | - | $235.09 M(+276.3%) |
| Mar 2023 | - | $62.47 M(+32.2%) |
| Dec 2022 | $47.25 M(+55.4%) | $47.25 M(-51.2%) |
| Sep 2022 | - | $96.78 M(+22.3%) |
| Jun 2022 | - | $79.11 M(+173.7%) |
| Mar 2022 | - | $28.90 M(-5.0%) |
| Dec 2021 | $30.41 M | $30.41 M(-1.0%) |
| Sep 2021 | - | $30.71 M(-45.5%) |
| Jun 2021 | - | $56.39 M(+1.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $55.82 M(-72.9%) |
| Dec 2020 | $206.15 M(+4056.3%) | $206.15 M(+220.3%) |
| Sep 2020 | - | $64.37 M(-1.5%) |
| Jun 2020 | - | $65.35 M(+50.0%) |
| Mar 2020 | - | $43.56 M(+778.3%) |
| Dec 2019 | $4.96 M(-96.0%) | $4.96 M(-58.5%) |
| Sep 2019 | - | $11.95 M(-38.3%) |
| Jun 2019 | - | $19.39 M(-27.1%) |
| Mar 2019 | - | $26.62 M(-78.8%) |
| Dec 2018 | $125.30 M(+469.0%) | $125.30 M(+203.0%) |
| Sep 2018 | - | $41.35 M(+62.7%) |
| Jun 2018 | - | $25.42 M(+15.4%) |
| Dec 2017 | $22.02 M(+89.9%) | $22.02 M |
| Dec 2016 | $11.59 M | - |
FAQ
- What is Sutro Biopharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Sutro Biopharma?
- What is Sutro Biopharma annual cash & cash equivalents year-on-year change?
- What is Sutro Biopharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Sutro Biopharma?
- What is Sutro Biopharma quarterly cash and cash equivalents year-on-year change?
What is Sutro Biopharma annual cash & cash equivalents?
The current annual cash & cash equivalents of STRO is $69.27 M
What is the all time high annual cash & cash equivalents for Sutro Biopharma?
Sutro Biopharma all-time high annual cash & cash equivalents is $206.15 M
What is Sutro Biopharma annual cash & cash equivalents year-on-year change?
Over the past year, STRO annual cash & cash equivalents has changed by +$22.01 M (+46.59%)
What is Sutro Biopharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of STRO is $174.58 M
What is the all time high quarterly cash and cash equivalents for Sutro Biopharma?
Sutro Biopharma all-time high quarterly cash and cash equivalents is $235.09 M
What is Sutro Biopharma quarterly cash and cash equivalents year-on-year change?
Over the past year, STRO quarterly cash and cash equivalents has changed by +$105.31 M (+152.03%)